Dykeman is co-chair of the law firm’s global Life Sciences & Medical Technology Group, co-managing shareholder of the firm’s Boston office, and the founding co-chair of the American Bar Association’s Medical Devices Committee. His practice focuses on securing worldwide intellectual property protection and related business strategy for high-tech clients, with particular experience in life sciences, medical devices, robotics, materials and information technology, the law firm said.
“Massachusetts is one of the thriving hubs for life sciences and medical technology companies, and Dave Dykeman is a go-to patent attorney for innovators in that region and across the country and globe,” Dykeman’s group co-chair, Wayne Elowe, said in a news release announcing the award.
LMG Life Sciences is considered the definitive guide to leading law firms and lawyers specializing in the life sciences industry across the U.S., Canada, Europe, Africa and the Middle East, the law firm said. The awards are based on marketplace and client feedback as well as information provided by firms.
Greenberg Traurig said Dykeman provides strategic patent portfolio development and intellectual property advice for major research institutions, multinational corporations and early-stage companies, among other clients. He also performs patent due diligence to assess patent portfolios for venture capital investment, mergers and acquisitions and licensing opportunities.
Dykeman has also authored expert contributions to Medical Design & Outsourcing, including advice on how design patents can provide extra protection for medical robots and building a strategic medtech patent portfolio.
Greenberg Traurig Vice Chair Lori Cohen, who is aksi co-chair of the firm’s Global Litigation Practice and its Trial Practice, was shortlisted for the LMG Life Sciences Product Liability Attorney of the Year award, the law firm said.